Avoiding Pitfalls In PE

Size: px
Start display at page:

Download "Avoiding Pitfalls In PE"

Transcription

1 UC SF Avoiding Pitfalls In PE Jeffrey Tabas, MD Professor UCSF School of Medicine Emergency Department San Francisco General Hospital sf g h Disclosure No Financial Relationships to Disclose No significant investments or savings Unlimited Expenses PreTest Probability PERC/D-dimer Radiology Treatment OUTLINE Are we spotting the clots without radiating the entire lot? 1. Are we assigning a pretest risk? - Low, Moderate, or High 2. Are we limiting radiation /contrast with the PERC rule and D-Dimers? 3. Do we understand the use of helical CT? 1

2 CASE #1 38 y.o. F, sudden onset, burning SSCP x 3 hrs Not pleuritic, positional, or radiating. No SOB No meds, Not a smoker, No other PMHx NAD, 120/80, 80, 18, 37.1, 96% Exam unremarkable ECG Normal CXR - Clear Risk Factors for Thromboembolism Family History Cancer CHF Prior thromboembolism Estrogen use / Pregnancy / Obesity Low Abdominal/Pelvic surgery/trauma < 6 mos LE Paralysis/ Immobility / Trauma Pain improved with viscous lidocaine and mylanta Risk Factors - Pearls Symptoms Signs Risk Factors increase your suspicion However 20% of patients with PE have no known Risk Factors Therefore Lack of Risk Factors by no means excludes PE Dyspnea = 73% v 59% RR > 20/min = 70% v 68% Pleuritic Pain = 66% v 43% Rales = 51% Cough = 37% v 25% Tachycardia = 30% v 23% Leg Swelling = 28% Loud P2 = 23% Leg Pain = 26% Temp > 38.5C = 7% v 17% Hemoptysis = 13% v 7% Wheezes = 5% Stein, Chest, 91 Miniati, Am J Resp CC Med, 99 2

3 Symptoms / Signs 97% with PE had at least ONE of the following Dyspnea Tachypnea Pleuritic pain Stein, Chest, 91 Signs/Symptoms - Pearls Dyspnea, Tachypnea, or Pleuritic CP the Triggers! History and Physical Exam Pitfalls Hx of VTE, surgery, leg swelling, estrogen use O2 Sat & Respiratory Rate - Measure yourself Examine and even measure the extremities Don t misinterpret non-specific findings (ex. Partially reproducible pain => Costochondritis) Most Recent Data Symptoms / Signs/ Risk Factors Courtney, AnnEM, Risk Factors/Signs/Sx s in 7940 ED pts Strongest predictors for PE (OR > 2): Hx of VTE Unilateral Leg Swelling O2 Sat < 95% Estrogen Use Surgery (GA) w/in 4 weeks EKG S Q Non-specific Tests Useful when it provides alternate Dx S1Q3T3 (+LR=3.7) Inverted T waves in V1-V4 (+LR=3.7) CXR Useful when it provides alternate Dx THampton s Hump, Westermark s sign 3

4 When Do I Start the Workup? When there is 1 of 3 findings: Dyspnea Tachypnea Pleuritic Chest Pain And no definitive alternate diagnosis CASE #1 - Review 38 y.o. F, sudden onset, burning CP x 3 hrs Not pleuritic, positional, or radiating. No SOB No meds, Not a smoker, No other PMHx NAD, 120/80, 80, 18, 37.1 Exam unremarkable ECG Normal, CXR Clear Resolved with GI Cocktail. Discharged home How Do I Choose a Risk Category? Gestalt vs Risk Factors Symptoms and Signs Presence of Alternate Diagnosis Clinical Decision Rules The Pitfall of Risk Stratification Pretest Probability Kline, JTH ED pts Low (2-15%) 3% Moderate (15-40%) 10% High (>40%) 31% 4

5 Clinical Decision Rules There Are Lots of Them Wells, Ann IM, 98 We don t remember them Runyon et al., Wells, Thr Haemo, 00 Acad EM, 2007 Wicki, Arch IM, 01 Kline, Ann EM, 02 Miniati, AM J Med, 03 Cinical Decision Rules They Don t Agree With Each Other Wells Wicki Kline Miniati HR > (HR/SBP) Immobile/Surgery Hx VTE Hemoptysis Advanced Age S/S of DVT + + Hypoxia + + Alternate Dx + Cancer + Risk Stratification - Pearls Gestalt appears equivalent to Algorithms Algorithms may be beneficial for trainees Algorithms may be beneficial for institutional uniformity The PERC rule PERC rule (like d-dimer) can eliminate the need for imaging Not a Clinical Decision Rule Apply AFTER Risk Strat Apply ONLY to Patients you have stratified as Low Risk If negative, no further evaluation is needed Kline, JA et al. JTH ED pts, 7% with VTE Sens = 97% Spec = 21% 5

6 The PERC rule NPPV = 99% (PERC Neg + Low Suspicion) Criteria 1. no prior VTE 5. Age < 50 years 2. no hemoptysis 6. SaO2= > 95% 3. no estrogen use 7. pulse < 100 bpm 4. no hospitalization for 8. no unilateral leg swelling trauma/surgery w/in 4 wks More Recent Literature Hugli, JTH, 10 The PERC rule Retrospectively applied PERC to 1675 pts 96.6% Sensitive (but only 79% in low risk pts) 16% Specific Significant limits to retrospective application CASE #1 38 y.o. F, sudden onset, burning SSCP x 3 hrs Not pleuritic, positional, or radiating. No SOB No meds, Not a smoker, No other PMHx NAD, 120/80, 80, 18, 37.1, 96% Exam unremarkable ECG Normal CXR - Clear = PERC Negative 1. no prior VTE 5. Age < no hemoptysis 6. SaO2= > 95% 3. no estrogen use 7. pulse < no trauma/surgery 8. no unilateral leg w/in 4 wks swelling Rapid D-Dimer Tests TEST Sensitivity Specificity Latex Agglutination Qualitative 75% 99% Quantitative 95% 50% ELISA Microplate 95% 50% ELFA 97% 43% Whole Blood (SimpliRed) 87% 69% 6

7 D-Dimer Pearls Understand your Radiologic Tests! If you plan to perform a CT scan, order a d-dimer first you can potentially eliminate the need. Don t order the d-dimer if you wouldn t get a CT scan without it! Negative ELFA + 15% risk Patient => EXCLUDES PE (1.5% chance) Negative ELFA + 30% risk Patient => DOESN T EXCLUDE PE (3% chance) Optimize success CTPA - Pearls 18 or 20 g proximal IV delivers 100 to 150 ml dye at 4 ml/sec Minimize Complications Ask IV insertor re: risk of infiltration, esp. antecubital/ej s Check for h/o Allergy Consider Bicarb protocol in everyone 7

8 Radiation Doses Stein, Radiology, 2007 Background radiation = 3 msv/yr PA and Lat CXR = 0.07 msv CTPA = 2 to 8 msv Abd/pelvis CT = 10 msv Smith-Bindman, Arch IM 09 - Actual Doses!!!! CTPA 10 (7-14) msv CT abdomen 16 msv Understand results CTPA - Pearls Ask about quality of main PA opacification Good > 200 hounsefield units Understand Risks Radiation in the young Kidneys in the old Outpatient Treatment? Outpatient Treatment? ACCP guidelines 2008 No randomized trials of Rx in-hospital vs. at-home. Some trials of early discharge. Some observational studies of pts Rx d at home. EurSC guidelines 2008 Outpatient Rx is conceivable Hull et al. Arch IM 1997 CAREFUL! Risk of recurrent PE was 25 percent if PTT was sub-therapeutic in first 24 hours in pooled analysis of 3 trials Aujesky, Lancet, 2011 RCT of 344 Low Risk PE pts (PESI class 1/2) to inpt vs outpt (took 3.5 yrs) Rx d with BID enox - No difference in safety Excluded hypoxia, BP < 100, receipt of IV pain meds, obese, unreliable (ETOH, homeless) Average ED stay=12 hrs 8

9 Case #2 48 y.o. M with recent LE ORIF presents with leg swelling, acute SOB and pleuritic CP. No PMH of cardiopulmonary disease PEx: BP 90/60, HR 105, RR 20, Afeb, Sat=93% How would you manage this patient? Thrombolytics Answer: Confirm PE by either CTPA or right heart strain on bedside US Rx with TPA 100 mg IV over 2 hours + Heparin 5000u bolus and drip ACCP Guideline, CHEST 2008 Level 1 rec for Thrombolysis If hemodynamic compromise 1B If Right Heart Strain AND Low Risk Bleeding 2B IVC Filters Use when anticoagulation contraindicated Do Not Use in addition to anticoagulation Decousus, N Engl J Med pts with DVT Compared Filter + Warfarin vs Warfarin alone No difference in outcomes! Summary Consider PE in the patient with: Pleuritic CP Dyspnea Tachypnea Assign a risk Gestalt vs Clinical algorithm Use the PERC rule if Negative, excludes disease when pretest is < 10% 9

10 Send a sensitive d-dimer Summary Negative excludes dz in pt with < 10-15% pretest prob Probably too non-specific for inpatients Understand your CT Pulmonary Angiogram Summary Most patients require initial admission for at least 24 hours Thrombolyse your hypotensive PE patients 10

Jeffrey Tabas, MD. sf g h. Risk Assessment Do we understand risk stratification? Are we limiting radiation /contrast with the PERC rule and D-Dimers?

Jeffrey Tabas, MD. sf g h. Risk Assessment Do we understand risk stratification? Are we limiting radiation /contrast with the PERC rule and D-Dimers? Pulmonary Embolism Update Jeffrey Tabas, MD Professor UCSF School of Medicine Emergency Department San Francisco General Hospital Disclosure No Financial Relationships to Disclose No significant investments

More information

Pulmonary Embolism. Pulmonary Embolism. Pulmonary Embolism. PE - Clinical

Pulmonary Embolism. Pulmonary Embolism. Pulmonary Embolism. PE - Clinical Pulmonary embolus - a practical approach to investigation and treatment Sam Janes Wellcome Senior Fellow and Respiratory Physician, University College London Background Diagnosis Treatment Common: 50 cases

More information

Pulmonary Embolism Rule-out Criteria - Is it good enough?

Pulmonary Embolism Rule-out Criteria - Is it good enough? Pulmonary Embolism Rule-out Criteria - Is it good enough? DR. IMRON SUBHAN MBBS, FEM (CMC), MRCEM CONSULTANT & HEAD DEPARTMENT OF EMERGENCY MEDICINE APOLLO HOSPITALS HYDERABAD INDIA GENERAL SECRETARY SOCIETY

More information

Updates in Management of Pulmonary Embolism (PE) David Ming, MD Duke Hospital Medicine July 24, 2017 Hilton Head, SC

Updates in Management of Pulmonary Embolism (PE) David Ming, MD Duke Hospital Medicine July 24, 2017 Hilton Head, SC Updates in Management of Pulmonary Embolism (PE) David Ming, MD Duke Hospital Medicine July 24, 2017 Hilton Head, SC Objectives Highlight clinical features and presentation of acute PE Analyze strategies

More information

Acute Pulmonary Embolism and Deep Vein Thrombosis. Barbara LeVarge MD Beth Israel Deaconess Medical Center Pulmonary Hypertension Center COPYRIGHT

Acute Pulmonary Embolism and Deep Vein Thrombosis. Barbara LeVarge MD Beth Israel Deaconess Medical Center Pulmonary Hypertension Center COPYRIGHT Acute Pulmonary Embolism and Deep Vein Thrombosis Barbara LeVarge MD Beth Israel Deaconess Medical Center Pulmonary Hypertension Center Acute PE and DVT No disclosures. Acute PE and DVT Learning objectives

More information

Thrombolysis in PE. Outline. Disclosure. Overview on Pulmonary Embolism. Hot Topics in Emergency Medicine 2012 Midyear Clinical Meeting

Thrombolysis in PE. Outline. Disclosure. Overview on Pulmonary Embolism. Hot Topics in Emergency Medicine 2012 Midyear Clinical Meeting Disclosure Thrombolysis in PE Daniel P. Hays, PharmD, BCPS, FASHP reports no relevant financial relationships. Daniel P. Hays, PharmD, BCPS, FASHP Outline 55 YOF presents to ED with SOB PMH of DVT + noncompliance

More information

Simplified approach to investigation of suspected VTE

Simplified approach to investigation of suspected VTE Simplified approach to investigation of suspected VTE Diagnosis of DVT and PE THSNA 2016, Chicago 15 April 2016 Clive Kearon, McMaster University, Canada Relevant Disclosures Research Support/P.I. Employee

More information

Understanding Best Practices in Anticoagulation Therapy in Patients with Venous Thromboembolism. Rajat Deo, MD, MTR

Understanding Best Practices in Anticoagulation Therapy in Patients with Venous Thromboembolism. Rajat Deo, MD, MTR Understanding Best Practices in Anticoagulation Therapy in Patients with Venous Thromboembolism Rajat Deo, MD, MTR Director of Translational Research in Cardiac Arrhythmias Division of Cardiovascular Medicine

More information

PULMONARY EMBOLISM (PE): DIAGNOSIS AND TREATMENT

PULMONARY EMBOLISM (PE): DIAGNOSIS AND TREATMENT PULMONARY EMBOLISM (PE): DIAGNOSIS AND TREATMENT OBJECTIVE: To provide a diagnostic algorithm and treatment options for patients with acute pulmonary embolism (PE). BACKGROUND: Venous thromboembolism (VTE)

More information

Low Risk Chest Pain. Objectives. Disclosure. Case 1. Jeffrey Tabas, MD Professor of Emergency Medicine Office of CME UCSF School of Medicine

Low Risk Chest Pain. Objectives. Disclosure. Case 1. Jeffrey Tabas, MD Professor of Emergency Medicine Office of CME UCSF School of Medicine Disclosure Low Risk Chest Pain No Financial Relationships to Disclose No significant investments or savings Unlimited Expenses Jeffrey Tabas, MD Professor of Emergency Medicine Office of CME UCSF School

More information

Cover Page. The handle holds various files of this Leiden University dissertation.

Cover Page. The handle  holds various files of this Leiden University dissertation. Cover Page The handle http://hdl.handle.net/1887/21764 holds various files of this Leiden University dissertation. Author: Mos, Inge Christina Maria Title: A more granular view on pulmonary embolism Issue

More information

Is it safe to manage pulmonary embolism in Primary Care? Roopen Arya King s College Hospital

Is it safe to manage pulmonary embolism in Primary Care? Roopen Arya King s College Hospital Is it safe to manage pulmonary embolism in Primary Care? Roopen Arya King s College Hospital A few definitions Safe Avoid death, recurrent thrombosis, bleeding Manage Diagnosis + treatment Pulmonary embolism

More information

Pulmonary embolism: Acute management. Cecilia Becattini University of Perugia, Italy

Pulmonary embolism: Acute management. Cecilia Becattini University of Perugia, Italy Pulmonary embolism: Acute management Cecilia Becattini University of Perugia, Italy Acute pulmonary embolism: Acute management Diagnosis Risk stratification Treatment Non-high risk PE: diagnosis 3-mo VTE

More information

PULMONARY EMBOLISM AND PERT. Jonathon Kirkland, DO OSU Department Chair, Radiology Head of Interventional Radiology

PULMONARY EMBOLISM AND PERT. Jonathon Kirkland, DO OSU Department Chair, Radiology Head of Interventional Radiology PULMONARY EMBOLISM AND PERT Jonathon Kirkland, DO OSU Department Chair, Radiology Head of Interventional Radiology No financial disclosures 1. What are the clinical signs/symptoms of submassive PE? 2.

More information

CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM. Gordon Lowe Professor of Vascular Medicine University of Glasgow

CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM. Gordon Lowe Professor of Vascular Medicine University of Glasgow CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM Gordon Lowe Professor of Vascular Medicine University of Glasgow VENOUS THROMBOEMBOLISM Common cause of death and disability 50% hospital-acquired

More information

PE and DVT. Dr Anzo William Adiga WatsApp or Call Medical Officer/RHEMA MEDICAL GROUP

PE and DVT. Dr Anzo William Adiga WatsApp or Call Medical Officer/RHEMA MEDICAL GROUP PE and DVT Dr Anzo William Adiga WatsApp or Call +256777363201 Medical Officer/RHEMA MEDICAL GROUP OBJECTIVES DEFINE DVT AND P.E PATHOPHYSIOLOGY OF DVT CLINICAL PRESENTATION OF DVT/PE INVESTIGATE DVT MANAGEMENT

More information

Clinical Guide - Suspected PE (Reviewed 2006)

Clinical Guide - Suspected PE (Reviewed 2006) Clinical Guide - Suspected (Reviewed 2006) Principal Developer: B. Geerts Secondary Developers: C. Demers, C. Kearon Background Investigation of patients with suspected pulmonary emboli () remains problematic

More information

Management of Acute Pulmonary Embolism. Judith Hurdman Consultant Respiratory Physician

Management of Acute Pulmonary Embolism. Judith Hurdman Consultant Respiratory Physician Management of Acute Pulmonary Embolism Judith Hurdman Consultant Respiratory Physician Judith.hurdman@sth.nhs.uk Overview Risk Stratification Who can be managed as an outpatient? To thrombolyse or not

More information

Case. Case. Management of Pulmonary Embolism in the ICU

Case. Case. Management of Pulmonary Embolism in the ICU Management of Pulmonary Embolism in the ICU Todd M Bull, M.D. Associate Professor of Medicine Division of Pulmonary Sciences and Critical Care Medicine Pulmonary Hypertension Center University of Colorado

More information

Imaging Pulmonary Embolism

Imaging Pulmonary Embolism May 2001 Imaging Pulmonary Embolism New ways to look at a diagnostic dilemma Emily Willner,, HMS III Core Radiology Clerkship, BIDMC New approaches to imaging PE: Agenda 1. Review two patients who had

More information

Venous Thromboembolic Disease Update

Venous Thromboembolic Disease Update Canadian Society of Internal Medicine Annual Meeting Calgary, Alberta, October 2014 Venous Thromboembolic Disease Update Benjamin Bell, MD FRCPC James Douketis, MD FRCPC On Behalf of Thrombosis Canada

More information

ED Diagnosis of DVT or tools to rule out DVT in your ED

ED Diagnosis of DVT or tools to rule out DVT in your ED ED Diagnosis of DVT or tools to rule out DVT in your ED Ralph Wang UCSF Department of Emergency Medicine 53 yo f c/o left leg swelling recent cholecystectomy its midnight how do you manage this patient?

More information

Diagnosis and Treatment of Pulmonary Embolism: High-Tech versus Low- Tech, which way to go?

Diagnosis and Treatment of Pulmonary Embolism: High-Tech versus Low- Tech, which way to go? Diagnosis and Treatment of Pulmonary Embolism: High-Tech versus Low- Tech, which way to go? Philip S. Wells MD, FRCPC, MSc Professor Chair and Chief, Department of Medicine, University of Ottawa DISCLOSURE

More information

PE service. 65 years old lady. What would you do next? Risk stratification. What would you do next? Regional College Lecture PE Management

PE service. 65 years old lady. What would you do next? Risk stratification. What would you do next? Regional College Lecture PE Management PE service Regional College Lecture PE Management Update in medicine (Eastern) Cambridge 29 th June 2017 Dr Rachel M Limbrey DM FRCP University Hospital Southampton NHS Foundation Trust Ambulatory acute

More information

PULMONARY EMBOLISM/VTE CARE PROCESS MODEL

PULMONARY EMBOLISM/VTE CARE PROCESS MODEL PULMONARY EMBOLISM/VTE CARE PROCESS MODEL IMCP FALL CONFERENCE 2017 Scott Stevens, MD Co-Director, Thrombosis Clinic & Thrombosis Research Group Intermountain Medical Center Professor of Clinical Medicine

More information

Risk factors for DVT. Venous thrombosis & pulmonary embolism. Anticoagulation (cont d) Diagnosis 1/5/2018. Ahmed Mahmoud, MD

Risk factors for DVT. Venous thrombosis & pulmonary embolism. Anticoagulation (cont d) Diagnosis 1/5/2018. Ahmed Mahmoud, MD Risk factors for DVT Venous thrombosis & pulmonary embolism Ahmed Mahmoud, MD Surgery ; post op especially for long cases, pelvic operations (THR), Trauma ; long bone fractures, pelvic fractures (posterior

More information

Venous thrombosis & pulmonary embolism. Ahmed Mahmoud, MD

Venous thrombosis & pulmonary embolism. Ahmed Mahmoud, MD Venous thrombosis & pulmonary embolism Ahmed Mahmoud, MD Risk factors for DVT Surgery ; post op especially for long cases, pelvic operations (THR), Trauma ; long bone fractures, pelvic fractures (posterior

More information

PE Pathway. The charts are listed as follows:

PE Pathway. The charts are listed as follows: PE Pathway This document comprises 6 simple flow charts to assist clinicians in the investigation and treatment of suspected or confirmed Acute Pulmonary Emboli. The pathway has been put together using

More information

Pulmonary Thromboembolism

Pulmonary Thromboembolism Pulmonary Thromboembolism James Allen, MD Epidemiology of Pulmonary Embolism 1,500,000 new cases per year in the United States Often asymptomatic 300,000 deaths per year DVT or PE present in 10% of ICU

More information

Anticoagulation Forum: Management of Tiny Clots

Anticoagulation Forum: Management of Tiny Clots Anticoagulation Forum: Management of Tiny Clots Casey O Connell, MD FACP Associate Professor Jane Anne Nohl Division of Hematology Keck School of Medicine USC DISCLOSURES None 4/11/2017 Objectives Define

More information

Single Center 4 year series of 114 consecutive patients treated for massive and submassive PE. Mark Goodwin, MD

Single Center 4 year series of 114 consecutive patients treated for massive and submassive PE. Mark Goodwin, MD Single Center 4 year series of 114 consecutive patients treated for massive and submassive PE Mark Goodwin, MD Disclosure Speaker name:... I have the following potential conflicts of interest to report:

More information

Updates in Diagnosis & Management of VTE

Updates in Diagnosis & Management of VTE Updates in Diagnosis & Management of VTE TRACY MINICHIELLO, MD CHIEF, ANTICOAGULATION& THROMBOSIS SERVICE-SAN FRANCISCO VAMC PROFESSOR OF MEDICINE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO Financial Disclosures-NONE

More information

Diagnostic Algorithms in VTE

Diagnostic Algorithms in VTE Diagnostic Algorithms in VTE Mark H. Meissner, MD Department of Surgery University of Washington School of Medicine Overutilization of Venous Duplex U/S 1983-1993 (Zweibel et al, Australasian Rad, 1995)

More information

CHAPTER 2 VENOUS THROMBOEMBOLISM

CHAPTER 2 VENOUS THROMBOEMBOLISM CHAPTER 2 VENOUS THROMBOEMBOLISM Objectives Venous Thromboembolism (VTE) Prevalence Patho-physiology Risk Factors Diagnosis Pulmonary Embolism (PE) Management of DVT/PE Prevention VTE Patho-physiology

More information

Epidemiology: Incidence VTE: Mortality Morbidity Risk Factors: Acute Chronic : Genetic

Epidemiology: Incidence VTE: Mortality  Morbidity Risk Factors: Acute Chronic : Genetic Submassive PE Pulmonary Embolism Epidemiology: Incidence VTE: 100-200/100,000 = 3rd most frequent cardiovascular disease Symptomatic DVT complicated by PE = 40-50% Sudden fatal PE = 34% Intermediate-risk

More information

UC SF. Division of General Internal Medicine UNIVERSITY OF CALIFORNIA SAN FRANCISCO, DIVISION OF HOSPITAL MEDICINE

UC SF. Division of General Internal Medicine UNIVERSITY OF CALIFORNIA SAN FRANCISCO, DIVISION OF HOSPITAL MEDICINE Updates in the Management of Venous Thromboembolism Margaret C. Fang, MD, MPH Associate Professor of Medicine UCSF Division of Hospital Medicine Medical Director, Anticoagulation Clinic Venous Thromboembolism

More information

Troponin = 35. Objectives. Low Risk Chest Pain. Does this patient have ACS? Does this patient have ACS? Objectives

Troponin = 35. Objectives. Low Risk Chest Pain. Does this patient have ACS? Does this patient have ACS? Objectives Objectives Low Risk Chest Pain Jeffrey Tabas, MD Professor of Emergency Medicine Office of CME UCSF School of Medicine Improve speed and accuracy in assessing patients with possible ACS! Avoid pitfalls

More information

MDCT and Pulmonary Embolism. Heber MacMahon The University of Chicago Department of Radiology

MDCT and Pulmonary Embolism. Heber MacMahon The University of Chicago Department of Radiology MDCT and Pulmonary Embolism Heber MacMahon The University of Chicago Department of Radiology https://tinyurl.com/hmpe2018 Disclosures Consultant for Riverain Medical Minor stockholder in Hologic, Inc.

More information

Evidence Based Medicine: Articles of Diagnosis

Evidence Based Medicine: Articles of Diagnosis Evidence Based Medicine: Articles of Diagnosis Duke University School of Medicine EBM Course March 5, 2013 Jamie Fox, MD David Ming, MD Departments of Internal Medicine and Pediatrics Diagnosis Diagnostic

More information

October 2017 Pulmonary Embolism

October 2017 Pulmonary Embolism October 2017 Pulmonary Embolism Prof. Ahmed BaHammam, FRCP, FCCP Professor of Medicine College of Medicine King Saud University 1 Objectives Epidemiology Pathophysiology Diagnosis Massive PE Treatment

More information

CARDIAC CHEST PAIN. 1. ST Elevation MI

CARDIAC CHEST PAIN. 1. ST Elevation MI CARDIAC CHEST PAIN ACUTE ST ELEVATION MYOCARDIAL INFARCTION* and ACUTE CORONARY SYNDROME (ACS) are caused by instability/rupture of atheromatous plaques in the coronary circulation. Identifying ST Elevation

More information

Disclosures. DVT: Diagnosis and Treatment. Questions To Ask. Dr. Susanna Shin - DVT: Diagnosis and Treatment. Acute Venous Thromboembolism (VTE) None

Disclosures. DVT: Diagnosis and Treatment. Questions To Ask. Dr. Susanna Shin - DVT: Diagnosis and Treatment. Acute Venous Thromboembolism (VTE) None Disclosures DVT: Diagnosis and Treatment None Susanna Shin, MD, FACS Assistant Professor University of Washington Acute Venous Thromboembolism (VTE) Deep Venous Thrombosis (DVT) Pulmonary Embolism (PE)

More information

RISK STRATIFICATION OF PATIENTS WITH ACUTE SYMPTOMATIC PULMONARY EMBOLISM. David Jiménez, MD, PhD, FCCP Ramón y Cajal Hospital, IRYCIS Madrid, Spain

RISK STRATIFICATION OF PATIENTS WITH ACUTE SYMPTOMATIC PULMONARY EMBOLISM. David Jiménez, MD, PhD, FCCP Ramón y Cajal Hospital, IRYCIS Madrid, Spain RISK STRATIFICATION OF PATIENTS WITH ACUTE SYMPTOMATIC PULMONARY EMBOLISM David Jiménez, MD, PhD, FCCP Ramón y Cajal Hospital, IRYCIS Madrid, Spain Potential Conflicts of Interest Financial conflicts of

More information

4/18/2018. Objectives. Background. 1) Compare and contrast the various validated tools for the identification of patients with pulmonary embolism

4/18/2018. Objectives. Background. 1) Compare and contrast the various validated tools for the identification of patients with pulmonary embolism Pulmonary Embolism: Assessment, risk-stratification, and treatment plan for the outpatient management of low-risk patients Presentation by Joshua T. Wood, PharmD/PGY-1 Resident Providence St. Patrick Hospital;

More information

Proper Diagnosis of Venous Thromboembolism (VTE)

Proper Diagnosis of Venous Thromboembolism (VTE) Proper Diagnosis of Venous Thromboembolism (VTE) Whal Lee, M.D. Seoul National University Hospital Department of Radiology 2 nd EFORT Asia Symposium, 3 rd November 2010, Taipei DVT - Risk Factors Previous

More information

Pulmonary Embolism Pathway

Pulmonary Embolism Pathway Pulmonary Embolism Pathway Ambulatory Care Pathway Dr. A. Zafar, Dr. A. Rehman, Dr. T. Malik September, 2011. Patient Identification Label Pulmonary Embolism Pathway Clinical History Comments Hospital

More information

Acute Management of Pulmonary Embolism

Acute Management of Pulmonary Embolism Acute Management of Pulmonary Embolism Dr Alex West Respiratory Consultant Guy s and St Thomas Hospital London Declarations - none Order of Play Up date in Diagnostic Imaging - CTPA and V:Q SPECT Sub-massive

More information

Epidemiology. Update on Pulmonary Embolism. Keys to PE Management 5/5/2014. Diagnosis. Risk stratification. Treatment

Epidemiology. Update on Pulmonary Embolism. Keys to PE Management 5/5/2014. Diagnosis. Risk stratification. Treatment Update on Pulmonary Embolism Steven M. Dean, DO, FACP, RPVI Program Director- Vascular Medicine Associate Professor of Internal Medicine Division of Cardiovascular Medicine The Ohio State University Keys

More information

Objectives. Venous Thromboembolism (VTE) Prophylaxis. Case VTE WHY DO IT? Question: Who Is At Risk?

Objectives. Venous Thromboembolism (VTE) Prophylaxis. Case VTE WHY DO IT? Question: Who Is At Risk? Objectives Venous Thromboembolism (VTE) Prophylaxis Rishi Garg, MD Department of Medicine Identify patients at risk for VTE Options for VTE prophylaxis Current Recommendations (based on The Seventh ACCP

More information

VTE General Background

VTE General Background VTE General Background VTE incidence is about 1:1000 persons annually >250,000 admissions for VTE annually >100,000 people die of PE annually >90% of PE s arise from lower limb DVT 50% of DVT at diagnosis

More information

Acute and long-term treatment of PE. Cecilia Becattini University of Perugia

Acute and long-term treatment of PE. Cecilia Becattini University of Perugia Acute and long-term treatment of PE Cecilia Becattini University of Perugia Acute and long-term treatment of VTE What is the optimal acute phase treatment for the patient? Intravenous thrombolysis One

More information

Radiologic Features of The Pulmonary Embolus

Radiologic Features of The Pulmonary Embolus January 2003 Radiologic Features of The Pulmonary Embolus Travis McGlothin HMSIII Mr. J is a 51 y.o. male who presented to the BIDMC ED w/ acute onset of: Lft. Hemiparesis slurred speech mild dyspnea mild

More information

No conflicts of interest

No conflicts of interest Robert M. Rodriguez, MD FAAEM Clinical Professor of Medicine and Emergency Medicine, UCSF No conflicts of interest Major Points Most ICU patients start in ED Chain of critical care starting in field and

More information

How to Diagnose Pulmonary Embolism anno 2014?

How to Diagnose Pulmonary Embolism anno 2014? How to Diagnose Pulmonary Embolism anno 2014? Mark H.H. Kramer, MD, PhD, FRCP FACP Professor of Medicine VU University Medical Center Amsterdam, The Netherlands What are we going to discuss? Age adjusted

More information

The Crashing Pediatric Patient: Stopping the Fall

The Crashing Pediatric Patient: Stopping the Fall The Crashing Pediatric Patient: Stopping the Fall I can t breathe... 4 year old BIBA from school with sudden severe resp distress Hx of asthma, food allergies Judith Klein, MD FACEP Assistant Professor

More information

Acute and long-term treatment of VTE. Cecilia Becattini University of Perugia

Acute and long-term treatment of VTE. Cecilia Becattini University of Perugia Acute and long-term treatment of VTE Cecilia Becattini University of Perugia Acute and long-term treatment of VTE The goals The acute PE phase After the acute phase Treatment for VTE Goals of acute treatment

More information

Ten conditions you can discharge early and safely from the MAPU? Stephen Dee General Physician

Ten conditions you can discharge early and safely from the MAPU? Stephen Dee General Physician Ten conditions you can discharge early and safely from the MAPU? Stephen Dee General Physician Which conditions? 1. Chest pain 2. Pneumonia 3. Cellulitis 4. PE 5. DVT 6. Syncope 7. GI bleed 8. TIA 9. Diabetes

More information

Mabel Labrada, MD Miami VA Medical Center

Mabel Labrada, MD Miami VA Medical Center Mabel Labrada, MD Miami VA Medical Center *1-Treatment for acute DVT with underlying malignancy is for 3 months. *2-Treatment of provoked acute proximal DVT can be stopped after 3months of treatment and

More information

Inferior Vena Cava Filters

Inferior Vena Cava Filters Inferior Vena Cava Filters and the American Society of Hematology Choosing Wisely Campaign Kevin P. Hubbard, DO, HMDC MACOI Chief - Division of Specialty Medicine Professor and Chair - Section of Internal

More information

MATERIALS AND METHODS

MATERIALS AND METHODS RETROSPECTIVE STUDY OF OPTIMISING THE USE OF COMPUTED TOMOGRAPHY PULMONARY ANGIOGRAPHY (CTPA) FOR THE DIAGNOSIS OF PULMONARY EMBOLISM IN PLACES WITH LIMITED RESOURCES P. V. Kalyan Kumar 1, Ramakrishna

More information

What s New in DVT & PE

What s New in DVT & PE What s New in DVT & PE Mark Buch MD CM CCFP(EM) Attending physician Emergency Department Jewish General Hospital Family Physician and Medical Director GMF Santé Mont-Royal Objectives: Review the diagnostic

More information

Inferior Venacaval Filters Valuable vs. Dangerous Valuable Annie Kulungowski. Department of Surgery Grand Rounds March 24, 2008

Inferior Venacaval Filters Valuable vs. Dangerous Valuable Annie Kulungowski. Department of Surgery Grand Rounds March 24, 2008 Inferior Venacaval Filters Valuable vs. Dangerous Valuable Annie Kulungowski Department of Surgery Grand Rounds March 24, 2008 History of Vena Cava Filters Virchow-1846-Proposes PE originate from veins

More information

Management of Pulmonary Embolism. Michael Hooper, M.D., MSc Associate Professor, Pulmonary and Critical Care Medicine Eastern Virginia Medical School

Management of Pulmonary Embolism. Michael Hooper, M.D., MSc Associate Professor, Pulmonary and Critical Care Medicine Eastern Virginia Medical School Management of Pulmonary Embolism Michael Hooper, M.D., MSc Associate Professor, Pulmonary and Critical Care Medicine Eastern Virginia Medical School I have no conflicts of interest to report. VTE Overview

More information

Medical Patients: A Population at Risk

Medical Patients: A Population at Risk Case Vignette A 68-year-old woman with obesity was admitted to the Medical Service with COPD and pneumonia and was treated with oral corticosteroids, bronchodilators, and antibiotics. She responded well

More information

Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine

Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine Venous thromboembolism: pulmonary embolism (PE) deep vein thrombosis (DVT) 1% of all patients admitted to hospital 5% of in-hospital mortality

More information

Low Molecular Weight Heparin for Prevention and Treatment of Venous Thromboembolic Disorders

Low Molecular Weight Heparin for Prevention and Treatment of Venous Thromboembolic Disorders SURGICAL GRAND ROUNDS March 17 th, 2007 Low Molecular Weight Heparin for Prevention and Treatment of Venous Thromboembolic Disorders Guillermo Escobar, M.D. LMWH vs UFH Jayer s sales pitch: FALSE LMW is

More information

Massive and Submassive Pulmonary Embolism: 2017 Update and Future Directions

Massive and Submassive Pulmonary Embolism: 2017 Update and Future Directions Massive and Submassive Pulmonary Embolism: 2017 Update and Future Directions Kush R Desai, MD Assistant Professor of Radiology Northwestern University Feinberg School of Medicine Chicago, IL Disclosures

More information

POCUS is the future of the physical exam

POCUS is the future of the physical exam Diagnostic Point of Care Ultrasound For Hospitalists Nima Afshar MD Associate Professor Trevor Jensen MD MS Assistant Professor Department of Medicine, UCSF Oct 2018 POCUS is the future of the physical

More information

Clots and Foamy Urine: Thrombotic Complications of Nephrotic Syndrome. Prayus Tailor, MD October 5, 2013 Renal and Hypertension Symposium

Clots and Foamy Urine: Thrombotic Complications of Nephrotic Syndrome. Prayus Tailor, MD October 5, 2013 Renal and Hypertension Symposium Clots and Foamy Urine: Thrombotic Complications of Nephrotic Syndrome Prayus Tailor, MD October 5, 2013 Renal and Hypertension Symposium Objectives Discuss the pathophysiology of thrombosis in nephrotic

More information

IVC FILTERS: A CASE REPORT REVIEWING THE INDICATIONS FOR PLACEMENT, RETRIEVAL AND ANTICOAGULATION

IVC FILTERS: A CASE REPORT REVIEWING THE INDICATIONS FOR PLACEMENT, RETRIEVAL AND ANTICOAGULATION IVC FILTERS: A CASE REPORT REVIEWING THE INDICATIONS FOR PLACEMENT, RETRIEVAL AND ANTICOAGULATION Resident(s): George Athanasatos Attending(s): Daniel Golwyn Program/Dept: Interventional Radiology CHIEF

More information

Canadian Society of Internal Medicine Annual Meeting 2016 Montreal, QC

Canadian Society of Internal Medicine Annual Meeting 2016 Montreal, QC Canadian Society of Internal Medicine Annual Meeting 2016 Montreal, QC 1 st workshop: update to VTE guidelines in 2016 2 nd workshop: VTE controversies + new horizons André Roussin MD, FRCP, CSPQ CHUM

More information

Too much medicine and venous thromboembolism: How can we make things Well again?

Too much medicine and venous thromboembolism: How can we make things Well again? Too much medicine and venous thromboembolism: How can we make things Well again? Emily G McDonald MD MSc; Assistant professor of medicine; McGill University Health Centre Canadian Society of Internal Medicine;

More information

Epidemiology of Thrombosis in Patients with Malignancy. Cancer and Venous Thromboembolism. Chew HK, Arch Int Med, Feb Blom et al, JAMA, Feb 2005

Epidemiology of Thrombosis in Patients with Malignancy. Cancer and Venous Thromboembolism. Chew HK, Arch Int Med, Feb Blom et al, JAMA, Feb 2005 Cancer and Venous Thromboembolism Objectives 1. Epidemiology of thrombosis in patients with malignancy 2. Anticancer agents and thrombosis 3. Current treatment protocols at UHN 4. Prevention of DVT 5.

More information

EXTENDING VTE PROPHYLAXIS IN ACUTELY ILL MEDICAL PATIENTS

EXTENDING VTE PROPHYLAXIS IN ACUTELY ILL MEDICAL PATIENTS EXTENDING VTE PROPHYLAXIS IN ACUTELY ILL MEDICAL PATIENTS Samuel Z. Goldhaber, MD Director, VTE Research Group Cardiovascular Division Brigham and Women s Hospital Professor of Medicine Harvard Medical

More information

Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (2012) NICE guideline CG144

Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (2012) NICE guideline CG144 Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (2012) NICE guideline CG144 Appendix A: Summary of new evidence from Summary of evidence from previous year Diagnosis Diagnostic

More information

Cover Page. The handle holds various files of this Leiden University dissertation

Cover Page. The handle   holds various files of this Leiden University dissertation Cover Page The handle http://hdl.handle.net/1887/40114 holds various files of this Leiden University dissertation Author: Exter, Paul L. den Title: Diagnosis, management and prognosis of symptomatic and

More information

Disclosures. Inpatient Management of Non-ST Elevation Acute Coronary Syndromes. Edward McNulty MD, FACC. None

Disclosures. Inpatient Management of Non-ST Elevation Acute Coronary Syndromes. Edward McNulty MD, FACC. None Inpatient Management of Non-ST Elevation Acute Coronary Syndromes Edward McNulty MD, FACC Assistant Clinical Professor UCSF Director, SF VAMC Cardiac Catheterization Laboratory Disclosures None New Guidelines

More information

Pulmonary Thromboembolism

Pulmonary Thromboembolism Pulmonary Thromboembolism Jing ZHANG ( 张静 ), MD, PhD zhang.jing@zs-hospital.sh.cn Department of Pulmonary Medicine Zhongshan Hospital Fudan University OUTLINE Understand the historical context of pulmonary

More information

Interventional Treatment VTE: Radiologic Approach

Interventional Treatment VTE: Radiologic Approach Interventional Treatment VTE: Radiologic Approach Hae Giu Lee, MD Professor, Dept of Radiology Seoul St. Mary s Hospital The Catholic University of Korea Introduction Incidence High incidence: 250,000-1,000,000/year

More information

NIH Public Access Author Manuscript Ann Emerg Med. Author manuscript; available in PMC 2011 April 1.

NIH Public Access Author Manuscript Ann Emerg Med. Author manuscript; available in PMC 2011 April 1. NIH Public Access Author Manuscript Published in final edited form as: Ann Emerg Med. 2010 April ; 55(4): 307 315.e1. doi:10.1016/j.annemergmed.2009.11.010. Clinical features from the history and physical

More information

Venous Thromboembolism (PE and DVT) Management in the ED

Venous Thromboembolism (PE and DVT) Management in the ED Venous Thromboembolism (PE and DVT) Management in the ED Haldun Akoglu, Assoc. Prof., MD Marmara University Department of Emergency Medicine December, 2014 What is Venous Thromboembolism (VTE)? VTE forms

More information

Disclosures. Objectives

Disclosures. Objectives BRIGHAM AND WOMEN S HOSPITAL Treatment of Massive and Submassive Pulmonary Embolism Gregory Piazza, MD, MS Assistant Professor of Medicine Harvard Medical School Staff Physician, Cardiovascular Division

More information

Venous Thromboembolism: Deep Venous Thrombosis and Pulmonary Embolism

Venous Thromboembolism: Deep Venous Thrombosis and Pulmonary Embolism Venous Thromboembolism: Deep Venous Thrombosis and Pulmonary Embolism MD Cardiovascular Interventions Orlando Objectives Recognize common presentations of deep venous thrombosis (DVT) and pulmonary embolus

More information

Pearls and Pitfalls in Emergency Medicine

Pearls and Pitfalls in Emergency Medicine Pearls and Pitfalls in Emergency Medicine Medicine Evolves and So Do We Objectives Review updates in emergency medicine pertinent to the Primary Care practitioner Low Back Pain Syncope Disclosure No Financial

More information

Duration of anticoagulation

Duration of anticoagulation Duration of anticoagulation P. Fontana Service d angiologie et d hémostase Hôpitaux Universitaires de Genève Pomeriggio formativo in coagulazione, Bellinzona, 19.10.2017 Conflict of interest AstraZeneca,

More information

The latest on the diagnosis and treatment of venous thromboembolism

The latest on the diagnosis and treatment of venous thromboembolism The latest on the diagnosis and treatment of venous thromboembolism Vicky Tagalakis MD FRCP Division of General Internal Medicine Jewish General Hospital McGill University Disclosures Advisory board Pfizer

More information

Diagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism

Diagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism Agency for Healthcare Research and Quality Evidence Report/Technology Assessment Diagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism Summary Number 68 Overview Venous thromboembolism

More information

Venous Thromboembolism Prophylaxis

Venous Thromboembolism Prophylaxis Approved by: Venous Thromboembolism Prophylaxis Vice President and Chief Medical Officer; and Vice President and Chief Operating Officer Corporate Policy & Procedures Manual Number: Date Approved January

More information

When to Scope in Lower GI Bleeding: It Must Be Done Now. Lisa L. Strate, MD, MPH Assistant Professor of Medicine University of Washington, Seattle, WA

When to Scope in Lower GI Bleeding: It Must Be Done Now. Lisa L. Strate, MD, MPH Assistant Professor of Medicine University of Washington, Seattle, WA When to Scope in Lower GI Bleeding: It Must Be Done Now Lisa L. Strate, MD, MPH Assistant Professor of Medicine University of Washington, Seattle, WA Outline Epidemiology Overview of available tests Urgent

More information

DV T Prophylaxis in Lower Extremity Surgery

DV T Prophylaxis in Lower Extremity Surgery DV T Prophylaxis in Lower Extremity Surgery MICHAEL R. JAFF, D.O. PRESIDENT, NEWTON -WELLESLEY HOSPITAL PROFESSOR OF MEDICINE, HARVARD MEDICAL SCHOOL Michael R. Jaff, D.O. Conflicts of Interest Consultant

More information

Pulmonary Embolism. Thoracic radiologist Helena Lauri

Pulmonary Embolism. Thoracic radiologist Helena Lauri Pulmonary Embolism Thoracic radiologist Helena Lauri 8.5.2017 Statistics 1-2 out of 1000 adults annually are diagnosed with deep vein thrombosis (DVT) and/or pulmonary embolism (PE) About half of patients

More information

Chapter 1. Introduction

Chapter 1. Introduction Chapter 1 Introduction Introduction 9 Even though the first reports on venous thromboembolism date back to the 13 th century and the mechanism of acute pulmonary embolism (PE) was unraveled almost 150

More information

Radiation Exposure in Pregnancy. John R. Mayo UNIVERSITY OF BRITISH COLUMBIA

Radiation Exposure in Pregnancy. John R. Mayo UNIVERSITY OF BRITISH COLUMBIA Radiation Exposure in Pregnancy John R. Mayo UNIVERSITY OF BRITISH COLUMBIA Illustrative Clinical Scenario 32 year old female 34 weeks pregnant with recent onset shortness of breath and central chest pain

More information

How long to continue anticoagulation after DVT?

How long to continue anticoagulation after DVT? How long to continue anticoagulation after DVT? Dr. Nihar Ranjan Pradhan M.S., DNB (Vascular Surgery), FVES(UK) Consultant Vascular Surgeon Apollo Hospital, Jubilee Hills, Hyderabad (Formerly Faculty in

More information

FAILURE. Matt Beecroft, MD

FAILURE. Matt Beecroft, MD FAILURE Matt Beecroft, MD 64 yo male with no real PMH Sitting on couch when sudden onset SOB Says he s been sweaty FIRST PATIENT OF THE WEEKEND HR 131, RR 28, 132/96, 93% RE-EXAM BP 229/130, HR 180s

More information

Updates in venous thromboembolism. Cecilia Becattini University of Perugia

Updates in venous thromboembolism. Cecilia Becattini University of Perugia Updates in venous thromboembolism Cecilia Becattini University of Perugia News for VTE Diagnosis Treatment the acute phase the agents Pulmonary embolism: diagnosis Vein ultrasonography Meta-analysis 15

More information

Venous Thrombosis. Magnitude of the Problem. DVT 2 Million PE 600,000. Death 60,000. Estimated Cost of VTE Care $1.5 Billion/year.

Venous Thrombosis. Magnitude of the Problem. DVT 2 Million PE 600,000. Death 60,000. Estimated Cost of VTE Care $1.5 Billion/year. Venous Thrombosis Magnitude of the Problem DVT 2 Million Postthrombotic Syndrome 800,000 PE 600,000 Death 60,000 Silent PE 1 Million Pulmonary Hypertension 30,000 Estimated Cost of VTE Care $1.5 Billion/year

More information

Update on the Management of Cancer Associated VTE

Update on the Management of Cancer Associated VTE Update on the Management of Cancer Associated VTE Jean M. Connors, MD 2018 Master Class Course Anticoagulation Management Services BWH/DFCI Hemostatic Antithrombotic Stewardship BWH Associate Professor

More information

Pulmonary Embolism..Diagnostic Approach and Algorithm. Tolulope Adesiyun Harvard Medical School, Year III Gillian Lieberman, MD

Pulmonary Embolism..Diagnostic Approach and Algorithm. Tolulope Adesiyun Harvard Medical School, Year III Gillian Lieberman, MD Pulmonary Embolism..Diagnostic Approach and Algorithm Tolulope Adesiyun Harvard Medical School, Year III Gillian Lieberman, MD Epidemiology of Pulmonary Embolism Pulmonary Embolus (PE): Thrombus originating

More information

RECOMMENDATIONS FOR THE MANAGEMENT OF MASSIVE AND SUBMASSIVE PULMONARY EMBOLISM IN ADULT PATIENTS.

RECOMMENDATIONS FOR THE MANAGEMENT OF MASSIVE AND SUBMASSIVE PULMONARY EMBOLISM IN ADULT PATIENTS. RECOMMENDATIONS FOR THE MANAGEMENT OF MASSIVE AND SUBMASSIVE PULMONARY EMBOLISM IN ADULT PATIENTS. Target Audience: Physicians managing adult patients with massive and submassive pulmonary emboli in the

More information